Log In
BCIQ
Print this Print this
 

BVF-007, CX717

Also known as: ampakine

  Manage Alerts
Collapse Summary General Information
Company RespireRx Pharmaceuticals Inc.
DescriptionAllosteric modulator of the AMPA-type glutamate receptor
Molecular Target AMPA glutamate receptor (GRIA) (GLUR)
Mechanism of ActionAMPA receptor enhancer
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationRespiratory distress syndrome (RDS)
Indication DetailsPrevent opioid-induced respiratory depression (RD) while preserving analgesic effect; Treat opioid-induced respiratory depression; Treat respiratory depression
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$25.0M

$10.0M

$15.0M


 Deals Details
Get a free BioCentury trial today